Pembrolizumab trials for Squamous Cell Carcinoma of the Head and Neck

All Pembrolizumab trials · All Squamous Cell Carcinoma of the Head and Neck trials

Phase breakdown

Recruiting trials studying Pembrolizumab for Squamous Cell Carcinoma of the Head and Neck

• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
  NCT05208762 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 62 locations
• Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
  NCT05329532 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
  NCT04787042 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations

Common questions

How many trials study Pembrolizumab for Squamous Cell Carcinoma of the Head and Neck?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.